Payment overview · 2025
General Payments
$32.54
2 reported records · 1 companies
Healthcare provider profile · identity verified
Aaron Scott Jordan, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease · SAN BERNARDINO, CA · NPI 1972573756
Verified facts
What the public records show
CMS Open Payments records show Aaron Scott Jordan, MD received $32.54 in general payments during 2025 across 2 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $32.54 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $32.54 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $32.54 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 38 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
38 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 886 | 118 |
| Atorvastatin Calcium | Atorvastatin Calcium | 573 | 165 |
| Furosemide | Furosemide | 481 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 464 | 136 |
| Gabapentin | Gabapentin | 431 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 403 | 118 |
| Eliquis | Apixaban | 390 | 85 |
| Metformin Hcl | Metformin Hcl | 366 | 100 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 345 | 88 |
| Pantoprazole Sodium | Pantoprazole Sodium | 341 | 85 |
| Carvedilol | Carvedilol | 321 | 87 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 285 | 74 |
| Potassium Chloride | Potassium Chloride | 283 | 73 |
| Nifedipine Er | Nifedipine | 281 | 71 |
| Lisinopril | Lisinopril | 280 | 87 |
| Omeprazole | Omeprazole | 259 | 68 |
| Alprazolam | Alprazolam | 252 | 41 |
| Levothyroxine Sodium | Levothyroxine Sodium | 252 | 74 |
| Lorazepam | Lorazepam | 235 | 41 |
| Simvastatin | Simvastatin | 219 | 62 |
| Azithromycin | Azithromycin | 211 | 84 |
| Atenolol | Atenolol | 208 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 203 | 66 |
| Losartan Potassium | Losartan Potassium | 201 | 63 |
| Glipizide | Glipizide | 194 | 55 |
| Tramadol Hcl | Tramadol Hcl | 185 | 49 |
| Oxycodone Hcl | Oxycodone Hcl | 172 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 159 | 22 |
| Clonidine Hcl | Clonidine Hcl | 158 | 39 |
| Ibuprofen | Ibuprofen | 155 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 150 | 46 |
| Warfarin Sodium | Warfarin Sodium | 144 | 31 |
| Allopurinol | Allopurinol | 143 | 34 |
| Memantine Hcl | Memantine Hcl | 139 | 21 |
| Trazodone Hcl | Trazodone Hcl | 135 | 31 |
| Lovastatin | Lovastatin | 134 | 44 |
| Xarelto | Rivaroxaban | 131 | 25 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 121 | 38 |
| Finasteride | Finasteride | 118 | 29 |
| Donepezil Hcl | Donepezil Hcl | 116 | 23 |
| Prednisone | Prednisone | 114 | 31 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 111 | 45 |
| Entresto | Sacubitril/Valsartan | 110 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 98 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 98 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 96 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 96 | 21 |
| Diclofenac Sodium | Diclofenac Sodium | 93 | 20 |
| Meloxicam | Meloxicam | 90 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 88 | 15 |
| Temazepam | Temazepam | 86 | 13 |
| Chlorthalidone | Chlorthalidone | 85 | 22 |
| Nitroglycerin | Nitroglycerin | 84 | 44 |
| Baclofen | Baclofen | 83 | 17 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 82 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 80 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 78 | 20 |
| Testosterone Cypionate | Testosterone Cypionate | 77 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 76 | 21 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 75 | 28 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 75 | 44 |
| Pregabalin | Pregabalin | 73 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 72 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 72 | 23 |
| Alendronate Sodium | Alendronate Sodium | 70 | 19 |
| Dicyclomine Hcl | Dicyclomine Hcl | 70 | 18 |
| Sertraline Hcl | Sertraline Hcl | 69 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 68 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 66 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 21 |
| Clonazepam | Clonazepam | 65 | 13 |
| Carisoprodol | Carisoprodol | 61 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 57 | 16 |
| Terazosin Hcl | Terazosin Hcl | 56 | 15 |
| Ketoconazole | Ketoconazole | 54 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 54 | 20 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 53 | 12 |
| Ezetimibe | Ezetimibe | 52 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 52 | 11 |
| Famotidine | Famotidine | 51 | 18 |
| Glimepiride | Glimepiride | 51 | suppressed |
| Levetiracetam | Levetiracetam | 51 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 50 | 13 |
| Meclizine Hcl | Meclizine Hcl | 50 | 12 |
| Sotalol | Sotalol Hcl | 50 | 11 |
| Amoxicillin | Amoxicillin | 49 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 48 | 15 |
| Jardiance | Empagliflozin | 48 | 11 |
| Loperamide | Loperamide Hcl | 47 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 47 | 12 |
| Topiramate | Topiramate | 46 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 45 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 44 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 42 | 11 |
| Diazepam | Diazepam | 41 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 13 |
| Morphine Sulfate Er | Morphine Sulfate | 39 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | 13 |
| Ozempic | Semaglutide | 38 | suppressed |
| Acyclovir | Acyclovir | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 37 | 11 |
| Colchicine | Colchicine | 37 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 37 | suppressed |
| Primidone | Primidone | 36 | suppressed |
| Folic Acid | Folic Acid | 35 | suppressed |
| Mirtazapine | Mirtazapine | 35 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 34 | suppressed |
| Estradiol | Estradiol | 34 | suppressed |
| Metolazone | Metolazone | 34 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 34 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | suppressed |
| Celecoxib | Celecoxib | 33 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 32 | suppressed |
| Latanoprost | Latanoprost | 32 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 11 |
| Felodipine Er | Felodipine | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | 13 |
| Valsartan | Valsartan | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 28 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Lactulose | Lactulose | 27 | suppressed |
| Naproxen | Naproxen | 27 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Cilostazol | Cilostazol | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 25 | suppressed |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 25 | suppressed |
| Multaq | Dronedarone Hcl | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Digoxin | Digoxin | 23 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 23 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 21 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 21 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 19 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 19 | suppressed |
| Glyburide | Glyburide | 18 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 17 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Ramipril | Ramipril | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 15 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 14 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Myrbetriq | Mirabegron | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Nexium | Esomeprazole Magnesium | 13 | suppressed |
| Praluent Pen | Alirocumab | 13 | suppressed |
| Prochlorperazine | Prochlorperazine | 13 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 13 | suppressed |
| Wera | Norethindrone-Ethin. Estradiol | 13 | suppressed |
| Zonisamide | Zonisamide | 13 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 12 | suppressed |
| Efavirenz-Emtric-Tenofov Disop | Efavirenz/Emtricit/Tenofovr Df | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Valtrex | Valacyclovir Hcl | 12 | suppressed |
| Xanax | Alprazolam | 12 | suppressed |
| Cephalexin | Cephalexin | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.54 · 2 records | Novo Nordisk Inc | Ozempic | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error